O. Petter Veiby

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors

Cornelis Jan Pronk, O. Petter Veiby, David Bryder et al. · The Journal of Experimental Medicine · 2011 · 191 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +25

The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.

Sten Eirik W. Jacobsen, Cecilie Okkenhaug, June H. Myklebust et al. · The Journal of Experimental Medicine · 1995 · 168 citations · Full text

Cell Therapy, Potent Synergistic Hgf, Immunology +16

The Effect of Strenuous Exercise, Calorie Deficiency and Sleep Deprivation on White Blood Cells, Plasma Immunoglobulins and Cytokines

Arne Bøyum, Pål Wiik, Elisabeth Gustavsson et al. · Scandinavian Journal of Immunology · 1996 · 153 citations

Physical Activity, Immunology, Immune System +21

Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis

Tobias Schmelzle, Arnaud Mailleux, Michael Overholtzer et al. · Proceedings of the National Academy of Sciences · 2007 · 143 citations · Full text

Apoptosis, Cell Death, Functional Role +16

The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta

O. Petter Veiby, F W Jacobsen, Lu Cui et al. · The Journal of Immunology · 1996 · 110 citations